The Refractory Overactive Bladder: Sacral NEuromodulation vs. BoTulinum Toxin Assessment (ROSETTA)

Amundsen C1, Richter H2, Menefee S3, Komesu Y4, Arya L5, Gregory W T6, Myers D7, Zyczynski H8, Vasavada S9, Nolen T10, Wallace D10, Meikle S11

Research Type

Clinical

Abstract Category

Overactive Bladder

Watch this session
Abstract 1
New Horizons in Lower Urinary Tract Symptoms
Scientific Podium Session 1
Wednesday 14th September 2016
08:35 - 08:50
Hall C
Clinical Trial Incontinence Neuromodulation Prospective Study Urgency Urinary Incontinence
1. Duke University, 2. University of Alabama, 3. Kaiser Permanente San Diego, 4. University of New Mexico, 5. University of Pennsylvania, 6. Oregon Health Science University, 7. Brown University, 8. University of Pittsburgh, 9. Cleveland Clinic, 10. RTI International, 11. NICHD
Presenter
C

Cindy Amundsen
Links

Abstract

17/04/2024 10:27:27